 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 03/02/2026 |
$24.21 |
$24.34 |
$22.73 |
$22.81 |
3.03M | | 03/03/2026 |
$22.34 |
$22.96 |
$22.28 |
$22.50 |
1.97M | | 03/04/2026 |
$23.05 |
$23.46 |
$22.15 |
$23.39 |
1.93M | | 03/05/2026 |
$22.87 |
$23.13 |
$22.08 |
$22.40 |
2.21M | | 03/06/2026 |
$22.04 |
$22.31 |
$21.63 |
$22.16 |
1.32M |
|
|
| Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on March 02, 2026, ACAD opened at $24.21, traded as high as $24.34 and as low as $22.73, and closed at $22.81. Trading volume was a total of 3.03M shares. On March 03, 2026, ACAD opened at $22.34, traded as high as $22.96 and as low as $22.28, and closed at $22.50. Trading volume was a total of 1.97M shares. On March 04, 2026, ACAD opened at $23.05, traded as high as $23.46 and as low as $22.15, and closed at $23.39. Trading volume was a total of 1.93M shares. On March 05, 2026, ACAD opened at $22.87, traded as high as $23.13 and as low as $22.08, and closed at $22.40. Trading volume was a total of 2.21M shares. On March 06, 2026, ACAD opened at $22.04, traded as high as $22.31 and as low as $21.63, and closed at $22.16. Trading volume was a total of 1.32M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/10/2016 |
|
| End date: |
03/06/2026 |
|
| Start price/share: |
$19.26 |
|
| End price/share: |
$22.16 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
15.06% |
|
| Average Annual Total Return: |
1.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$11,502.03 |
|
| Years: |
9.99 |
|
|
|
| Date |
Close |
| 03/02/2026 | $22.81 | | 03/03/2026 | $22.50 | | 03/04/2026 | $23.39 | | 03/05/2026 | $22.40 | | 03/06/2026 | $22.16 |
|
|
Free ACAD Email Alerts:
